A new medicine for the treatment of chronic pain is on the market, produced by Cannabis Science.
And you guessed it, it’s marijuana. But you don’t inhale it. It’s delivered to the body in the first of its kind skin patch.
Cannabis Science Incorporated is a U.S. company that specializes in the development of cannabinoid-based medicines. As part of its new product-development plans, it will soon release the first batch of a CBIS Transdermal Patch.The patch contains high-potency cannabinoid (CBD) extract, the second major cannabinoid in marijuana after tetrahydrocannabinol (THC). CBD has all the anti-inflammatory and pain-relieving properties without any psychoactive effects, and research has demonstrated that it can be an effective treatment for inflammatory pain.
The niche for this patch is huge as thousands of people with chronic pain who choose to self medicate over prescription pain killers prefer a more“natural” medicine. . The patch is targeted to help many forms of chronic pain conditions including Neuropathy, Fibromyalgia, Diabetic Nerve Pain and Back Strains.
The patch is described by Cannabis Science to ““promote healing to an injured area of the body.”
Also, according to the company, “the CBIS medicated adhesive transdermal patch is placed on the skin to deliver a specific dose of cannabinoid medications into the bloodstream. Self-medicating patients have been reporting promoted healing effects to specific injured areas of the body experiencing chronic pain. An advantage of a transdermal drug delivery route over other types of medication delivery such as oral, topical, intravenous, intramuscular, etc. is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive which will be containing high potency cannabinoid (CBD) extract that slowly enters into the bloodstream and then penetrates the central nervous system of the patient delivering the pain relief sought.”
The patch is not being sold yet in California dispensaries but the company thinks sometime in the second quarter of 2018, it will be available with specific dispensaries that partner with Cannabis Science.